Wakefield, MA, United States of America

Aine Blanchard


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aine Blanchard: Innovator in Restriction Endonucleases

Introduction

Aine Blanchard is a prominent inventor based in Wakefield, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of high fidelity restriction endonucleases. Her innovative work has implications for various applications in genetic engineering and molecular biology.

Latest Patents

Aine Blanchard holds 1 patent for her invention titled "High fidelity restriction endonucleases." This patent provides compositions and methods for enzymes with altered properties, utilizing a systematic approach to mutagenesis. The screening assay she developed allows for the selection of desired proteins, particularly suited for modifying specific properties of restriction endonucleases, such as star activity. The compositions include restriction endonucleases with reduced star activity, defined by an overall fidelity index improvement factor.

Career Highlights

Aine Blanchard is currently associated with New England Biolabs, Inc., where she continues to advance her research and innovations. Her work has positioned her as a key figure in the biotechnology sector, contributing to the development of tools that enhance genetic research.

Collaborations

Aine collaborates with esteemed colleagues, including Zhenyu Zhu and Shuang-Yong Xu. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of molecular biology.

Conclusion

Aine Blanchard's contributions to the field of biotechnology, particularly through her patent on high fidelity restriction endonucleases, highlight her role as an influential inventor. Her work continues to impact genetic engineering and molecular biology, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…